Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors

BOULDER, Colo., Dec. 20, 2017 (GLOBE NEWSWIRE) — Findings Published in the American Association for Cancer Research (AACR) peer-reviewed journal Cancer Immunology Research demonstrate that a test based on a protein signature associated with Patient outcome in metastatic melanoma can effectively predict survival in patients receiving PD-1 blocking antibodies. The test, developed with Biodesix’s proprietary Diagnostic Cortex® machine learning platform, is based on mass spectrometry analysis of patient serum. “Understanding the biology of immune-resistant patients is critical to providing those patients with optimal therapy,” said Dr. Jeffrey Weber, Deputy Director of the Laura and Isaac Perlmutter Cancer Center at NYU-Langone, […]

Share the post

Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors

×

Subscribe to Bloggerwave Inc. Is In The Stockguru Spotlight For October 22, 2010 | Stockguru Smallcap Alerts On Penny Stocks

Get updates delivered right to your inbox!

Thank you for your subscription

×